-
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter studyGwon HC, Hahn JY, Kim HS et al. -
Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMIGiustino G, Mehran R, Stone GW et al.
-
Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD: The ASET Pilot StudyN Kogame, PO Guimarães, PA Lemos et al.
-
State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation - past, present and future perspectives.Gargiulo G, Valgimigli M, Capodanno D et al.
-
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)Kim BK, Hong MK, RESET Investigators.
-
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert PanelD Capodanno, MC Morice, DJ Angiolillo et al.
-
Prasugrel versus clopidogrel in patients with acute coronary syndromesWiviott SD, Braunwald E, TRITON-TIMI 38 Investigators.
-
Cost-Effectiveness of Different Durations of Dual-Antiplatelet Use After Percutaneous Coronary InterventionArbel Y, Bennell MC, Wijeysundera HC et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
